ArticleCureus2026
Indocyanine Green-Guided Lateral Pelvic Sentinel Lymph Node Mapping in Low Rectal Cancer: Toward a Selective Alternative to Systematic Sidewall Lymphadenectomy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The management of advanced low rectal cancer is shaped by an ongoing tension between two surgical philosophies regarding lateral pelvic lymph node (LPLN) disease. Eastern and Western guidelines diverge on whether systematic lateral lymph node dissection (LLND) should accompany total mesorectal excision (TME), reflecting different views of the locoregional behavior of LPLN involvement and different thresholds for accepting the urinary and sexual morbidity that accompanies full sidewall clearance. In this editorial, we argue that intraoperative interrogation of each individual case offers a way to refine, rather than resolve by regional consensus, this geography-driven dichotomy, and that indocyanine green (ICG) near-infrared fluorescence provides a principled means of individualizing the extent of lateral dissection. Peritumoral submucosal injection of ICG enables real-time visualization of lymphatic drainage and intraoperative identification of lateral pelvic sentinel lymph nodes (LPSLNs), which can be biopsied and submitted for frozen section. It is important to distinguish between the two applications of this signal. As an intraoperative visualization adjunct, ICG improves lateral node retrieval, and the supporting comparative evidence is relatively consistent. As a sentinel-based decision tool for safely omitting lateral dissection when the sentinel node is negative, the concept is promising but rests on a smaller and less mature evidence base; it remains investigational and requires validation in larger prospective studies with long-term oncologic and functional outcomes before it can guide the omission of lateral dissection in practice. We outline the operative protocol used in our department, extended from sentinel node mapping for gynecological malignancies, and place it in the context of contemporary systematic, propensity-matched, and prospective sentinel biopsy series. In our view, fluorescence-assisted selective LLND may serve as a pragmatic bridge between existing paradigms, preserving the oncologic intent of Japanese-style lateral clearance while aligning with Western priorities of minimizing unnecessary morbidity through tailored, image-guided surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.